Dishman Carbogen Amcis Limited has informed the Exchange regarding Appointment of Mr Dhaval R Shah as Non- Executive Director of the company w.e.f. August 12, 2025.
DCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dishman Carbogen Amcis announced multiple board decisions on August 12, 2025. Mr. Dhaval R. Shah (Chartered Accountant with 19+ years of experience) was appointed as Non-Executive and Non-Independent Director. Mrs. Deohooti J. Vyas (mother of Global MD Mr. Arpit J. Vyas) was re-appointed as Whole-time Director for 5 years effective September 3, 2026. The Board approved a fund raising proposal of up to ₹1,000 crore (₹10,000 million) through equity shares, QIPs, or preferential issue, and an increase in authorised share capital from ₹34.05 crore to ₹38 crore. On the financial front, consolidated Q1 FY26 results showed a strong turnaround with total income of ₹732.80 crore (up from ₹525.21 crore in Q1 FY25) and a net profit of ₹23.41 crore versus a loss of ₹77.57 crore in the year-ago quarter. EPS stood at ₹1.49 compared to ₹(4.95) previously.
The sharp swing to profitability in Q1 FY26 and strong revenue growth are positive signals for shareholders, though the proposed ₹1,000 crore fund raise could lead to equity dilution depending on the final structure. The re-appointment of a promoter family member and addition of a finance-experienced director reinforce continuity in governance.